Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Sep 4;2015(9):CD006716.
doi: 10.1002/14651858.CD006716.pub3.

Interventions for the treatment of metastatic extradural spinal cord compression in adults

Reena George  1 , Jenifer Jeba, Govindaraj Ramkumar, Ari G Chacko, Prathap Tharyan
Affiliations
Review

Interventions for the treatment of metastatic extradural spinal cord compression in adults

Reena George et al. Cochrane Database Syst Rev. .

Abstract

Background: Metastatic extradural spinal cord compression (MESCC) is treated with radiotherapy, corticosteroids, and surgery, but there is uncertainty regarding their comparative effects. This is an updated version of the original Cochrane review published in theCochrane Database of Systematic Reviews (Issue 4, 2008).

Objectives: To determine the efficacy and safety of radiotherapy, surgery and corticosteroids in MESCC.

Search methods: In March 2015, we updated previous searches (July 2008 and December 2013) of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, CINAHL, LILACS, CANCERLIT, clinical trials registries, conference proceedings, and references, without language restrictions. We also contacted experts for relevant published, unpublished and ongoing trials.

Selection criteria: Randomised controlled trials (RCTs) of radiotherapy, surgery and corticosteroids in adults with MESCC.

Data collection and analysis: Three authors independently screened and selected trials, assessed risk of bias, and extracted data. We sought clarifications from trial authors. Where possible, we pooled relative risks with their 95% confidence intervals, using a random effects model if heterogeneity was significant. We assessed overall evidence-quality using the GRADE approach.

Main results: This update includes seven trials involving 876 (723 evaluable) adult participants (19 to 87 years) in high-income countries. Most were free of the risk of bias. Different radiotherapy doses and schedulesTwo equivalence trials in people with MESCC and a poor prognosis evaluated different radiotherapy doses and schedules. In one, a single dose (8 Gray (Gy)) of radiotherapy (RT) was as effective as short-course RT (16 Gy in two fractions over one week) in enhancing ambulation in the short term (65% versus 69%; risk ratio (RR) was 0.93, (95% confidence interval (CI) 0.82 to 1.04); 303 participants; moderate quality evidence). The regimens were also equally effective in reducing analgesic and narcotic use (34% versus 40%; RR 0.85, 95% CI 0.62 to 1.16; 271 participants), and in maintaining urinary continence (90% versus 87%; RR 1.03, 95% CI 0.96 to 1.1; 303 participants) in the short term (moderate quality evidence). In the other trial, split-course RT (30 Gy in eight fractions over two weeks) was no different from short-course RT in enhancing ambulation (70% versus 68%; RR 1.02, 95% CI 0.9 to 1.15; 276 participants); reducing analgesic and narcotic use (49% versus 38%; RR 1.27, 95% CI 0.96 to 1.67; 262 participants); and in maintaining urinary continence (87% versus 90%; RR 0.97, 0.93 to 1.02; 275 participants) in the short term (moderate quality evidence). Median survival was similar with the three RT regimens (four months). Local tumour recurrence may be more common with single-dose compared to short-course RT (6% versus 3%; RR 2.21, 95% CI 0.69 to 7.01; 303 participants) and with short-course compared to split-course RT (4% versus 0%; RR 0.1, 95% CI 0.01 to 1.72; 276 participants), but these differences were not statistically significant (low quality evidence). Gastrointestinal adverse effects were infrequent with the three RT regimens (moderate quality evidence), and serious adverse events or post-radiotherapy myelopathy were not noted.We did not find trials comparing radiotherapy schedules in people with MESCC and a good prognosis. Surgery plus radiotherapy compared to radiotherapyLaminectomy plus RT offered no advantage over RT in one small trial with 29 participants (very low quality evidence). In another trial that was stopped early for apparent benefit, decompressive surgery plus RT resulted in better ambulatory rates (84% versus 57%; RR 1.48, 95% CI 1.16 to 1.90; 101 participants, low quality evidence). Narcotic use may also be lower, and bladder control may also be maintained longer than with than RT in selected patients (low quality evidence). Median survival was longer after surgery (126 days versus 100 days), but the proportions surviving at one month (94% versus 86%; RR 1.09, 95% CI 0.96 to 1.24; 101 participants) did not differ significantly (low quality evidence). Serious adverse events were not noted. Significant benefits with surgery occurred only in people younger than 65 years. High dose corticosteroids compared to moderate dose or no corticosteroidsData from three small trials suggest that high-dose steroids may not differ from moderate-dose or no corticosteroids in enhancing ambulation (60% versus 55%; RR 1.08, 95% CI 0.81 to 1.45; 3 RCTs, 105 participants); survival over two years (11% versus 10%; RR 1.11, 95% CI 0.24 to 5.05; 1 RCT, 57 participants); pain reduction (78% versus 91%; RR 0.86, 95% CI 0.62 to 1.20; 1 RCT, 25 participants); or urinary continence (63% versus 53%; RR 1.18, 95% CI 0.66 to 2.13; 1 RCT, 34 participants; low quality evidence). Serious adverse effects were more frequent with high-dose corticosteroids (17% versus 0%; RR 8.02, 95% CI 1.03 to 62.37; 2 RCTs, 77 participants; moderate quality evidence).None of the trials reported satisfaction with care or quality of life in participants.

Authors' conclusions: Based on current evidence, ambulant adults with MESCC with stable spines and predicted survival of less than six months will probably benefit as much from one dose of radiation (8 Gy) as from two doses (16 Gy) or eight doses (30 Gy). We are unsure if a single dose is as effective as two or more doses in preventing local tumour recurrence. Laminectomy preceding radiotherapy may offer no benefits over radiotherapy alone. Decompressive surgery followed by radiotherapy may benefit ambulant and non-ambulant adults younger than 65 years of age, with poor prognostic factors for radiotherapy, a single area of compression, paraplegia for less than 48 hours, and a predicted survival of more than six months. We are uncertain whether high doses of corticosteroids offer any benefits over moderate doses or indeed no corticosteroids; but high-dose steroids probably significantly increases the risk of serious adverse effects. Early detection; and treatment based on neurological status, age and estimated survival, are crucial with all treatment modalities. Most of the evidence was of low quality. High-quality evidence from more trials is needed to clarify current uncertainties, and some studies are in progress.

PubMed Disclaimer

Conflict of interest statement

RG: declares no financial or academic conflicts of interest

JJ: declares no financial or academic conflicts of interest

RJG: declares no financial or academic conflicts of interest

ACG: declares no financial or academic conflicts of interest

PT: declares no financial or academic conflicts of interest

Figures

1
1
PRISMA flow diagram depicting study selection
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
4
4
Forest plot of comparison: 1 High dose versus no or moderate dose corticosteroids, outcome: 1.2 Serious drug related adverse effects.
1.1
1.1. Analysis
Comparison 1 High dose versus no or moderate dose corticosteroids, Outcome 1 Overall ambulation (short term).
1.2
1.2. Analysis
Comparison 1 High dose versus no or moderate dose corticosteroids, Outcome 2 Serious drug related adverse effects.
See this image and copyright information in PMC

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

References to studies included in this review

Graham 2006 {published data only}
    1. Graham PH, Capp A, Delaney G, Goozee G, Hickey B, Turner S, et al. A pilot randomised comparison of dexamethasone 96 mg vs 16 mg per day for malignant spinal‐cord compression treated by radiotherapy: TROG 01.05 Superdex study. Clinical Oncology (R Coll Radiol) 2006;18(1):70‐6. [NCT00193869] - PubMed
Maranzano 2005 {published data only}
    1. Kwok Y, Patchell RA, Regine WF. Journal of Clinical Oncology. 2005; Vol. 23 (32):8272‐4. - PubMed
    1. Kwok Y, Regine WF, Patchell RA. Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo [comment on: Journal of Clinical Oncology 2005;23(15),3358‐65]. Journal of Clinical Oncology 2005;23(15):3308‐10. - PubMed
    1. Macbeth F, Stephens R, Hoskin P. Radiation dose in spinal cord compression. Comment on: Radiation therapy alone for spinal cord compression: time to improve upon a relatively ineffective status quo. [J Clin Oncol. 2005 20;23(15):3308‐10]. Journal of Clinical Oncology 2005;23(32):8270. - PubMed
    1. Maranzano E, Bellavita R, Rossi R. Radiotherapy alone or surgery in spinal cord compression? The choice depends on accurate patient selection. Journal of Clinical Oncology 2005; Vol. 23, issue 32:8270‐2. - PubMed
    1. Maranzano E, Bellavita R, Rossi R, Angelis V, Frattegiani A, Bagnoli R, et al. Short‐course versus split‐course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trial. Journal of Clinical Oncology 2005;23(15):3358‐65. - PubMed
Maranzano 2009 {published data only}
    1. Maranzano E, Trippa F, Casale M, Anselmo P, Rossi R. Reirradiation of metastatic spinal cord compression: definitive results of two randomized trials. Radiotherapy and Oncology 2011;98(2):234‐7. - PubMed
    1. Maranzano E, Trippa F, Casale M, Costantini S, Lupattelli M, Bellavita R, et al. 8Gy single‐dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial. Radiotherapy and Oncology 2009;93(2):174‐9. - PubMed
Patchell 2005 {published data only}
    1. Chi GH, Gokaslan Z, McCormick P, Tibbs PA, Kryscio RJ, Patchell RA. Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?:results from a randomized clinical trial. Spine (Phila Pa 1976) 2009;34(5):431‐5. - PubMed
    1. Furlan JC, Chan KK, Sandoval GA, Lam KC, Klinger CA, Patchell RA, et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology 2012;14(5):631‐40. - PMC - PubMed
    1. Furlan JC, Chan KKW, Sandoval G, Lam KC, Klinger CA, Patchell RA, et al. An Ontario‐based cost‐utility analysis comparing the standard of care with direct decompressive surgical resection followed by radiotherapy in the palliative care of patients with metastatic spinal cord cancer. Canadian Journal of Neurological Sciences. [Conference Abstract]. 2011:1) S12.
    1. Koch M, Keyser J. Surgical resection in metastatic spinal cord compression. Lancet 2006; Vol. 367, issue 9505:109. - PubMed
    1. Kunkler I. Surgical resection in metastatic spinal cord compression. Lancet 2006; Vol. 367, issue 9505:109. - PubMed
Sorensen 1994 {published data only}
    1. Sorensen S, Helweg‐Larsen S, Mouridsen H, Hansen HH. Effect of high‐dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. European Journal of Cancer 1994;30A(1):22‐7. - PubMed
Vecht 1989 {published data only}
    1. Vecht CJ, Haaxma‐Reiche H, Putten WL, Visser M, Vries EP, Twijnstra A. Initial bolus of conventional versus high‐dose dexamethasone in metastatic spinal cord compression. Neurology 1989;39(9):1255‐7. - PubMed
Young 1980 {published data only}
    1. Young RF, Post EM, King GA. Treatment of spinal epidural metastases: randomized prospective comparison of laminectomy and radiotherapy. Journal of Neurosurgery 1980;53:741‐8. - PubMed

References to studies excluded from this review

Aviles 2002 {published data only}
    1. Aviles A, Fernandez R, Gonzalez JL, Garcia EL, Neri N, Talavera A, et al. Spinal cord compression as a primary manifestation of aggressive malignant lymphomas: long‐term analysis of treatments with radiotherapy, chemotherapy or combined therapy. Leukemia & Lymphoma 2002;43(2):355‐9. - PubMed
Chaichana 2008 {published data only}
    1. Chaichana KL, Woodworth GF, Sciubba DM, McGirt MJ, Witham TJ, Bydon A, et al. Predictors of ambulatory function after decompressive surgery for metastatic epidural spinal cord compression. Neurosurgery. 2008;62(3):683‐92. - PubMed
Holden 2011 {published data only}
    1. Holden L, Loblaw A. Recombinant human erythropoietin (r‐HuEPO) in the prevention of neurologic sequelae from malignant spinal cord compression (MSCC): A multicenter, placebo‐controlled, phase 2 randomized study. Journal of Medical Imaging and Radiation Sciences. [Conference Abstract] 2011;42(3):155.
Hunter 2008 {published data only}
    1. Hunter RE, Wigfield CC. Direct decompressive surgical resection in the treatment of spinal cord compression caused by metastatic cancer: A randomized trial. British Journal of Neurosurgery 2008;22(5):13‐4. - PubMed
Mannion 2007 {published data only}
    1. Mannion RJ, Wilby M, Godward S, Lyratzopoulos G, Laing RJC. The surgical management of metastatic spinal disease: prospective assessment and long‐term follow‐up. British Journal of Neurosurgery. 2007;21(6):593‐8. - PubMed
Rades 2009 {published data only}
    1. Rades D, Douglas S, Veninga T, Stalpers LJ, Hoskin PJ, Bajrovic A, et al. Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression. Cancer 2010;116(15):3670‐3. - PubMed
    1. Rades D, Lange M, Veninga T, Rudat V, Bajrovic A, Stalpers LJ, et al. Preliminary results of spinal cord compression recurrence evaluation (score‐1) study comparing short‐course versus long‐course radiotherapy for local control of malignant epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics 2009;73(1):228‐34. - PubMed
Ryu 2010 {published data only}
    1. Ryu S, Rock J, Jain R, Lu M, Anderson J, Jin J‐Y, et al. Radiosurgical decompression of metastatic epidural compression. Cancer 2010;116(9):2250‐7. - PubMed
Schaefer 2012 {published data only}
    1. Schaefer C, Viezens L, Vettorazzi E, Wellbrock J, Hansen‐Algenstaedt N. Prospective clinical trial of minimal‐invasive instrumentation of the spine in spinal metastasis‐benefit or dead end. European Spine Journal. [Conference Abstract]. 2012;21(11):2395‐6.

References to studies awaiting assessment

Hegazy 2012 {published data only (unpublished sought but not used)}
    1. Hegazy, M, Wahba, H. Single‐ versus multi‐fraction radiation treatment for metastatic spinal cord compression: Functional outcome study Neurology. Conference. 64th American Academy of Neurology Annual Meeting New Orleans, LA United States. Conference Start. 20120421 Conference End: 20120428. Conference Publication: (var.pagings). 22 April 2012.

References to ongoing studies

ISRCTN97555949 {unpublished data only}
    1. A randomised feasibility study of single fraction radiotherapy compared to multi‐fraction radiotherapy in patients with metastatic spinal cord compression. http://controlled‐trials.com, UK Clinical Trials Gateway. [CRUK‐UCL‐BRD‐07‐010; EU‐20863; NCT00727584]
NCT00968643 {unpublished data only}
    1. A randomised phase III trial of two fractionation schemes in the treatment of malignant spinal cord compression (Spinal Cord Compression. ICORG 05‐03, V6). http://clinicaltrials.gov/show/NCT00968643. [CDR0000644307; EU‐20952; ICORG‐05‐03]

Additional references

Balshem 2011
    1. Balshem H, Helfand M, Schünemann HJ, Oxman AD, Kunz R, Brozek J, et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology 2011;64(4):401‐6. - PubMed
Bassler 2010
    1. Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta‐regression analysis. JAMA 2010;303(12):1180‐7. - PubMed
Chi 2009
    1. Chi JH, Gokaslan Z, McCormick P, Tibbs PA, Kryscio RJ, Patchell RA. Selecting treatment for patients with malignant epidural spinal cord compression‐does age matter?: results from a randomized clinical trial. Spine (Phila Pa 1976). 2009;34(5):431‐5. - PubMed
Choi 2010
    1. Choi D, Crockard A, Bunger C, Harms J, Kawahara N, Mazel C, et al. Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. European Spine Journal 2010;19(2):215‐22. - PMC - PubMed
CONSORT 2010
    1. Schulz KF, Altman DG, Moher D, CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. PLoS Medicine 2010;7(3):e1000251. - PMC - PubMed
Deeks 2011
    1. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta‐analyses. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Delattre 1989
    1. Delattre JY, Arbit E, Thaler HT, Rosenblum MK, Posner JB. A dose‐response study of dexamethasone in a model of spinal cord compression caused by epidural tumor. Journal of Neurosurgery 1989;70(6):920‐5. - PubMed
Falkmer 2003
    1. Falkmer U, Jarhult J, Wersall P, Cavallin‐Stahl E. A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncologica 2003;42(5/6):620‐33. - PubMed
Furlan 2012
    1. Furlan JC, Chan KK, Sandoval GA, Lam KC, Klinger CA, Patchell RA, et al. The combined use of surgery and radiotherapy to treat patients with epidural cord compression due to metastatic disease: a cost‐utility analysis. Neuro‐oncology 2012 2012;14(5):631‐40. - PMC - PubMed
GRADE 2004 [Computer program]
    1. GRADE Working Group. GRADE Profiler; version 3.6. GRADE Working Group, 2004.
Gradepro 2008 [Computer program]
    1. Jan Brozek, Andrew Oxman, Holger Schünemann. GRADEpro. Version 3.2 for Windows. GRADE Working Group, 2008.
Guyatt 2012
    1. Guyatt GH, Briel M, Glasziou P, Bassler D, Montori V. Problems of stopping trials early. BMJ 2012;344:e3863. - PubMed
Heimdal 1992
    1. Heimdal K, Hirschberg H, Slettebo H, Watne K, Nome O. High incidence of serious side effects of high‐dose dexamethasone treatment in patients with epidural spinal cord compression. Journal of Neuroncology 1992;12(2):141‐4. - PubMed
Helweg‐Larsen 2000
    1. Helweg‐Larsen S, Sorensen PS, Kreiner S. Prognostic factors in metastatic spinal cord compression: a prospective study using multivariate analysis of variables including survival and gait function in 153 patients. International Journal of Radiation Oncology, Biology and Physics 2000;46(5):1163‐9. - PubMed
Higgins 2003
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta‐analyses. BMJ 2003;327:557‐60. - PMC - PubMed
Higgins 2011a
    1. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Higgins 2011b
    1. Higgins JPT, Deeks JJ, Altman DG. Chapter 16: Special topics in statistics. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Holt 2012
    1. Holt T, Hoskin P, Maranzano E, Sahgal A, Schild SE, Ryu S, et al. Malignant epidural spinal cord compression: the role of external beam radiotherapy. Current Opinion in Supportive and Palliative Care 2012;6(1):103‐8. - PubMed
Kim 2012
    1. Kim JM, Losina E, Bono CM, Schoenfeld AJ, Collins JE, Katz JN, et al. Clinical outcome of metastatic spinal cord compression treated with surgical excision ± radiation versus radiation therapy alone: a systematic review of literature. Spine (Philadelphia, Pa.: 1976) 2012;37(1):78‐84. - PMC - PubMed
Klimo 2004
    1. Klimo P, Schmidt MH. Surgical management of spinal metastases. Oncologist 2004;9(2):188‐96. - PubMed
Klimo 2005
    1. Klimo P, Thompson CJ, Kestle JRW, Schmidt MHS. A meta‐analysis of surgery versus conventional radiotherapy for the treatment of metastatic spinal epidural disease. Neuro‐oncology 2005;7(1):64‐76. - PMC - PubMed
Laperriere 1996
    1. Laperriere NJ. The management of spinal cord compression. Toronto, Ontario, Canada, Princess Margaret Hospital 1996.
Loblaw 1998
    1. Loblaw DA, Laperriere NJ. Emergency treatment of malignant spinal cord compression: an evidence based guideline. Journal of Clinical Oncology 1998;16(4):1613‐24. - PubMed
Loblaw 2003
    1. Loblaw DA, Laperriere NJ, Mackillop WJ. A population‐based study of malignant spinal cord compression in Ontario. Clinical Oncology (R Coll Radiol) 2003;15(4):211‐7. - PubMed
Loblaw 2005
    1. Loblaw A, Perry J, Chambers A, Laperriere NJ. Systematic review of the diagnosis and management of malignant extradural spinal cord compression: The Cancer Care Ontario Practice Guidelines Initiative's Neuro‐oncology Disease Site Group. Journal of Clinical Oncology 2005;23:2028‐37. - PubMed
Loblaw 2012
    1. Loblaw DA, Mitera G, Ford M, Laperriere NJ. A 2011 updated systematic review and clinical practice guideline for the management of malignant extradural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics 2012;84(2):312‐7. - PubMed
L’espérance 2012
    1. L'espérance S, Vincent F, Gaudreault M, Ouellet JA, Li M, Tosikyan A, Goulet S, Comité de l’évolution des pratiques en oncologie. Treatment of metastatic spinal cord compression: cepo review and clinical recommendations.. Current Oncology 2012;19(6):e478‐90. - PMC - PubMed
Maranzano 1991
    1. Maranzano E, Latini P, Checcaglini F, Ricci S, Panizza BM, Aristei C, et al. Radiation therapy in metastatic spinal cord compression. A prospective analysis of 105 consecutive patients. Cancer 1991;67(5):1311‐7. - PubMed
Maranzano 2007
    1. Maranzano E, Trippa F. Be careful in getting cost effectiveness conclusions from a debatable trial. International Journal of Radiation Oncology, Biology, Physics 2007;68(1):314. - PubMed
MECIR 2011
    1. Chandler J, Churchill R, Higgins J, Lasserson T, Tovey D. Methodological Expectations of Cochrane Intervention Reviews (MECIR). Methodological standards for the conduct of new Cochrane Intervention Reviews. Version 2.1, 8 December 2011. Available at: http://www.editorial‐unit.cochrane.org/sites/editorial‐unit.cochrane.org/files/uploads/MECIR_... (accessed on 27 March 2012).
Molina 2011
    1. Molina CA, Gokaslan ZL, Sciubba DM. A systematic review of the current role of minimally invasive spine surgery in the management of metastatic spine disease. International Journal of Surgical Oncology 2011;2011:598148. [DOI: 10.1155/2011/598148] - DOI - PMC - PubMed
NICE 2008
    1. National Institute for Clinical Excellence (NICE). CG 75 Metastatic spinal cord compression. Available at: http://guidance.nice.org.uk/CG75/NICEGuidance/pdf 2008 (accessed 10 December 2013).
Rades 2000
    1. Rades D, Blach M, Bremer M, Wildfang I, Karstens JH, Heidenreich F. Prognostic significance of the time of developing motor deficits before radiation therapy in metastatic spinal cord compression: one‐year results of a prospective trial. International Journal of Radiation Oncology Biology Physics 2000;48(5):1403‐8. - PubMed
Rades 2004
    1. Rades D, Fehlauer F, Stalpers LJ, Wildfang I, Zschenker O, Schild SE. A prospective evaluation of two radiotherapy schedules with 10 versus 20 fractions for the treatment of metastatic spinal cord compression: final results of a multicenter study. Cancer 2004;101(11):2687‐92. - PubMed
Rades 2006
    1. Rades D, Fehlauer F, Schulte R, Veninga T, Stalpers LJ, Basic H, et al. Prognostic factors for local control and survival after radiotherapy of metastatic spinal cord compression. Journal of Clinical Oncology 2006;20(24):3388‐93. - PubMed
Rades 2008
    1. Rades D, Rudat V, Veninga T, Stalpers LJ, Hoskin PJ, Schild SE. Prognostic factors for functional outcome and survival after re‐irradiation for in‐field recurrences of metastatic spinal cord compression. Cancer 2008;113:1090‐6. - PubMed
Rades 2010a
    1. Rades D, Douglas S, Veninga T, Stalpers LJ, Hoskin PJ, Bajrovic A, et al. Validation and simplification of a score predicting survival in patients irradiated for metastatic spinal cord compression. Cancer 2010;116(15):3670‐3. - PubMed
Rades 2010b
    1. Rades D, Huttenlocher S, Dunst J, Bajrovic A, Karstens JH, Rudat V, et al. Matched pair analysis comparing surgery followed by radiotherapy and radiotherapy alone for metastatic spinal cord compression. Journal of Clinical Oncology 2010;28(22):3597‐604. - PubMed
Rades 2011a
    1. Rades D, Lange M, Veninga T, Stalpers LJ, Bajrovic A, Adamietz IA, et al. Final results of a prospective study comparing the local control of short‐course and long‐course radiotherapy for metastatic spinal cord compression. International Journal of Radiation Oncology, Biology, Physics 2011;79(2):524‐30. - PubMed
Rades 2011b
    1. Rades D, Huttenlocher S, Bajrovic A, Karstens JH, Adamietz IA, Kazic N, et al. Surgery followed by radiotherapy versus radiotherapy alone for metastatic spinal cord compression from unfavorable tumors. International Journal of Radiation Oncology, Biology, Physics 2011;81(5):e861‐8. - PubMed
Rades 2012
    1. Rades D, Huttenlocher S, Evers JN, Bajrovic A, Karstens JH, Rudat V, et al. Do elderly patients benefit from surgery in addition to radiotherapy for treatment of metastatic spinal cord compression?. Strahlentherapie und Onkologie 2012;188(5):424‐30. - PubMed
Rades 2013
    1. Rades D, Veninga T, Bajrovic A, Karstens JH, Schild SE. A validated scoring system to identify long‐term survivors after radiotherapy for metastatic spinal cord compression. Strahlentherapie und Onkologie 2013;189(6):462‐6. - PubMed
RevMan 5.3 [Computer program]
    1. The Nordic Cochrane Centre. Review Manager (RevMan). Version Version 5.3. Copenhagen: The Cochrane Collaboration, 2014.
Schaberg 1985
    1. Schaberg J, Gainor BJ. A profile of metastatic carcinoma of the spine. Spine 1985;10:19‐20. - PubMed
Schünemann 2011
    1. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results drawing conclusions. Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011.
Sciubba 2010
    1. Sciubba DM, Petteys RJ, Dekutoski MB, Fisher CG, Fehlings MG, Ondra SL, et al. Diagnosis and management of metastatic spine disease. A review. Journal of Neurosurgery. Spine 2010;13(1):94‐108. - PubMed
Thomas 1996
    1. Thomas KC, Nosyk B, Fisher CG, Dvorak M, Patchell RA, Regine WF, et al. Cost‐effectiveness of surgery plus radiotherapy vs. radiotherapy alone for treatment of metastatic epidural spinal cord compression. International Journal of Radiation Oncology, Biology, Physics 2006;66:1212‐8. - PubMed
Tokuhashi 2005
    1. Tokuhashi Y, Matsuzaki H, Oda H, Oshima M, Ryu J. A revised scoring system for preoperative evaluation of metastatic spine tumor prognosis. Spine (Phila Pa 1976) 2005;30(9):2186‐91. - PubMed
Tokuhashi 2009
    1. Tokuhashi Y, Ajiro Y, Umezawa N. Outcome of treatment for spinal metastases using scoring system for preoperative evaluation of prognosis. Spine (Phila Pa 1976) 2009;34(1):69‐73. - PubMed
Tomita 2001
    1. Tomita K, Kawahara N, Kobayashi T, Yoshida A, Murakami H, Akamaru T. Surgical strategy for spinal metastases. Spine 2001;26(3):298‐306. - PubMed
Ushio 1977
    1. Ushio Y, Posner R, Posner JB, Shapiro WR. Experimental spinal cord compression by epidural neoplasms. Neurology 1977; Vol. 27, issue 5:422‐9. - PubMed
Van der Linden 2005
    1. Linden YM, Dijkstra SP, Vonk EJ, Marijnen CA, Leer JW, Dutch Bone Metastasis Study Group. Prediction of survival in patients with metastases in the spinal column: results based on a randomized trial of radiotherapy. Cancer 2005;103(2):320‐8. - PubMed
Wang 2004
    1. Wang JC, Boland P, Mitra N, Yamada Y, Lis E, Stubblefield M, et al. Single‐stage posterolateral transpedicular approach for resection of epidural metastatic spine tumors involving the vertebral body with circumferential reconstruction: results in 140 patients. Journal of Neurosurgery. Spine 2004;1(3):287‐98. - PubMed
Wise 1999
    1. Wise JJ, Fischgrund JS, Herkowitz HN, Montgomery D, Kurz LT. Complication, survival rates, and risk factors of surgery for metastatic disease of the spine. Spine 1999;24(18):1943‐51. - PubMed
Witham 2006
    1. Witham TF, Khavkin YA, Gallia GL, Wolinsky JP, Gokaslan ZL. Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nature Clinical Practice Neurology 2006;2:87‐94. - PubMed
Wong 1990
    1. Wong DA, Fornasier VL, MacNab I. Spinal metastases: the obvious, the occult, and the impostors. Spine 1990;15:1‐4. - PubMed

References to other published versions of this review

George 2008
    1. George R, Jeba J, Ramkumar G, Chacko AG, Leng M, Tharyan P. Interventions for the treatment of metastatic extradural spinal cord compression in adults. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD006716] - DOI - PubMed